News
INCR
5.15
-3.20%
-0.17
Weekly Report: what happened at INCR last week (0928-1002)?
Weekly Report · 2d ago
Weekly Report: what happened at INCR last week (0921-0925)?
Weekly Report · 09/28 09:17
Weekly Report: what happened at INCR last week (0914-0918)?
Weekly Report · 09/21 09:17
Weekly Report: what happened at INCR last week (0907-0911)?
Weekly Report · 09/14 09:18
InterCure Regains Nasdaq Compliance With Minimum Bid Price Requirement
NASDAQ · 09/09 08:04
InterCure Regains Nasdaq Compliance After Delisting Warning
TipRanks · 09/08 20:27
InterCure Regains Nasdaq Compliance
Benzinga · 09/08 20:13
Weekly Report: what happened at INCR last week (0831-0904)?
Weekly Report · 09/07 09:17
Weekly Report: what happened at INCR last week (0824-0828)?
Weekly Report · 08/31 09:18
InterCure Raises $5 Million in August Private Placement to Rebuild Nir Oz Facility
TipRanks · 08/26 20:58
InterCure Secures NIS 230 Million Settlement; Reverse Stock Split Effective Today; Stock Up
NASDAQ · 08/24 14:44
InterCure reaches settlement with Israeli Tax Authorities, Compensation Fund
TipRanks · 08/24 11:30
InterCure Secures NIS 230 Million War-Damage Settlement to Rebuild Nir Oz Facility
TipRanks · 08/24 11:27
Weekly Report: what happened at INCR last week (0817-0821)?
Weekly Report · 08/24 09:18
INC Research trading halted, news pending
TipRanks · 08/21 23:50
InterCure Moves To Regain Nasdaq Compliance With 1-for-5 Reverse Share Split
NASDAQ · 08/19 15:59
InterCure to effect one-for-five reverse split
TipRanks · 08/19 13:15
Weekly Report: what happened at INCR last week (0810-0814)?
Weekly Report · 08/17 09:18
InterCure Shareholders Approve Proposal at August 11 Extraordinary Meeting
TipRanks · 08/11 13:56
Weekly Report: what happened at INCR last week (0803-0807)?
Weekly Report · 08/10 09:17
More
Webull provides a variety of real-time INCR stock news. You can receive the latest news about Intercure Ltd. through multiple platforms. This information may help you make smarter investment decisions.
About INCR
InterCure Ltd. is an Israel-based company engaged in the medical cannabis industry. Through its wholly owned subsidiary, Canndoc Ltd., the Company cultivates, produces, processes, markets, and distributes medical cannabis products. Its operations include the development and manufacture of pharmaceutical-grade medical cannabis products produced in accordance with Good Manufacturing Practice (GMP) standards. The Company offers a range of cannabis-based products for medical use and operates across various stages of the medical cannabis value chain, including cultivation, manufacturing, logistics, distribution, and retail activities. In addition, the Company is involved in the import, export, and commercialization of medical cannabis products and related healthcare solutions in Israel and selected international markets.